$AGX

Argan vs. MYR Group: Which Power-Buildout Stock Offers Better Value?

Argan (NYSE:AGX) and MYR Group (NASDAQ:MYRG) are power infrastructure contractors. Argan reported Q3 revenue of $384M, up 61.5%, with net income of $53.3M. It has $1.03B in cash but $440M in working capital. Backlog decreased to $2.52B. Investors should monitor contract awards and project timing. Hedge fund ownership of Argan slightly declined in Q2 2026.

Original reporting
Published Oct 7, 2026, 2:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 3:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Argan vs. MYR Group: Which Power-Buildout Stock Offers Better Value? — source image
Decision brief

The 30-second read

$AGXNeutralLow
01

Why it matters

The article provides no new information beyond what was disclosed in Argan's September 2 earnings release; therefore, it offers little actionable insight.

02

Market read

Low relevance; the article is a recap/comparative analysis without fresh data.

03

What to watch

Potential future contract awards or policy changes could shift the sector, but they are not covered here.

Relevance 4/10Novelty 2/10Timing: none

Background

The piece compares two power‑buildout contractors, Argan (AGX) and MYR Group (MYRG), using recently released Q3 results for Argan and generic growth metrics for both firms.

Company-level read

Ticker impact

$AGXNeutralMedium confidence
Context

Recaps Argan's Q3 results (revenue $384M, net income $53.3M) and cash balance, which were already public on Sep 2.

Expected impact

no clear directional impact

Evidence & confidence

The numbers are a repeat of the September 2 release; traders have already priced the information.

$MYRGNeutralMedium confidence
Context

Mentioned only as a peer comparison to Argan in a value‑vs‑growth discussion; no new company‑specific news.

Expected impact

no clear directional impact

Evidence & confidence

MYR Group receives no new information beyond being a benchmark; no trading decision implied.

Market effects

Reinforces the broader power‑construction sector's growth narrative but adds no fresh data.

Limited to U.S. construction equities; no broader regional effect.

Minimal; the article is a recap of U.S. company earnings.

Counterpoint

Without new catalysts, any short‑term price moves are likely driven by market noise rather than fundamentals.

Key entities

  • Argan, Inc.

    U.S. power‑generation construction contractor (ticker AGX).

  • MYR Group Inc.

    U.S. transmission and distribution contractor (ticker MYRG).

Related articles

$MYRGHigh

Jefferies upgrades MYR Group stock rating on utility spending outlook

Jefferies upgraded MYR Group (NASDAQ:MYRG) to Buy, lowering its price target to $370. The firm expects strong utility spending and labor conditions to benefit MYR Group, raising its EBITDA and EPS estimates. MYR Group reported Q2 2026 earnings of $3.17 per share and revenue of $1.08 billion, up 20% year-over-year. Goldman Sachs adjusted its price target to $422, maintaining a Neutral rating.

$AGXMedAI 8/10

Argan’s (AGX) Power Boom Comes With A Margin Catch

Argan (AGX) reported record Q2 revenue of $384.0M (+61.5% YoY) and net income of $53.3M, driven by its Power segment. Gross margin slipped to 19.3%, and backlog decreased to $2.5B. The company is debt-free with $1.03B in cash, returning $51.7M to shareholders. Management expects new projects but faces regulatory challenges and margin compression.

$AGXHigh

Why Argan Stock Swooned by Almost 8% Today

Argan (AGX) stock fell 8% after Piper Sandler analyst Dimple Gosai initiated coverage with an underweight rating and a $273 price target, citing capacity limits and a potential peak in project awards.

$AGXMed

Argan (AGX) Q2 2027 Earnings Call Transcript

Argan (AGX) reported Q2 2027 revenue of $384.0M, up 61.5%, with net income of $53.3M ($3.76 per diluted share). Power segment revenue grew 53% YoY to $301M, while Industrial segment revenue rose 111% to $76M. Consolidated backlog decreased to $2.5B. The company plans to complete a new fabrication facility in North Carolina by Q3 2027.

$AGXMedAI 8/10

Is Argan Worth Buying as Growth Surges but Valuation Stays Elevated?

Argan, Inc. (AGX) reported 56.5% revenue growth to $674.9M and adjusted EBITDA growth to $126.5M in H1 2027. The company expects 45.4% sales and 38% earnings growth for fiscal 2027, with a $2.5B backlog. However, margins have declined, and valuation remains high. Management highlights multi-year visibility but warns of execution risks.